absci.com - ABSI Total Company Value-to-Revenue Ratio

Official company branding of Absci Corporation (ABSI)

Absci performance remains independent of market cycles, relying on contracts with pharmaceutical giants. This GURU.Markets chart, presented as an EV/Sales multiple, illustrates the asset's reaction to the cost of capital, where 833973.15 captures the magnitude of this parameter. Absci synthesizes AI and biology to accelerate protein design, developing IT tools through strategic alliances and laboratory acquisitions.

ABSI Absci Corp: Company Value to Revenue in the range 11/23/2025 - 11/19/2026

ABSI (Absci Bio): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental company valuation:ABSI, Absci
Product sample of Absci Corp.

The stable geopolitical status of Absci makes it an attractive asset for long-term capital. The EV/Sales metric assesses the market value of the business, including net debt, relative to sales volume. By analyzing the EV/Sales level of Absci, an investor determines the real value of production capacities without the influence of leverage. The humanitarian nature of biomedicine minimizes the volatility risks of this indicator, which confirms the fundamental stability of the business model.

Competitor analysis for Absci

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)